Knight Therapeutics Inc. (TSX: GUD)

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 95.57M CAD in the quarter ending June 30, 2024, with 6.30% growth. This brings the company's revenue in the last twelve months to 337.87M, up 3.50% year-over-year. In the year 2023, Knight Therapeutics had annual revenue of 328.20M with 11.80% growth.

• Revenue (ttm): 337.87M
• Revenue Growth: +3.50%
• P/S Ratio: 1.72
• Revenue / Employee: 466.03K
• Employees: 725
• Market Cap: 569.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	328.20M	34.64M	11.80%
Dec 31, 2022	293.56M	50.09M	20.57%
Dec 31, 2021	243.48M	43.96M	22.03%
Dec 31, 2020	199.52M	152.06M	320.39%
Dec 31, 2019	47.46M	34.96M	279.69%